文献速递中枢神经肿瘤放疗放疗物理与技术

伽玛刀ICON单次与多次分次放射外科的比较:单中心回顾

A Comparison of Single Fraction and Multi Fraction Radiosurgery on the Gamma Knife ICON: A Single Institution Review.
PubMed 文献 · Adv Radiat Oncol · 2022-12-28

本单中心回顾纳入200例接受单次立体定向放射外科(SRS)或分次SRS(fSRS)治疗的完整脑转移瘤患者,比较预测因素与结局。fSRS唯一预测因素为肿瘤体积>2.061 cm3;分次或生物有效剂量对局部失败、毒性或生存无差异。从计划到治疗间隔10天与局部失败相关,1年局部控制率在该间隔前治疗者为96.48%、后治疗者为76.92%(P = .0005)。

要点

  • fSRS唯一预测因素为肿瘤体积>2.061 cm3。
  • 分次或生物有效剂量对局部失败、毒性或生存无差异。
  • 计划至治疗间隔10天与局部失败相关,1年局部控制率间隔前96.48% vs 间隔后76.92%(P = .0005)。

核心结论

  • 分次立体定向放射外科是体积较大、不适合单次SRS患者的安全有效替代方案。
  • 应尽快治疗这些患者,因为本研究中延迟显示影响局部控制。

研究设计与样本

  • 单中心回顾性研究,纳入200例接受SRS或fSRS治疗完整脑转移瘤的患者。
  • 采用逻辑回归识别fSRS预测因素,Cox回归识别生存预测因素,Kaplan-Meier分析计算生存、局部失败和远处失败率。
  • 生成受试者工作特征曲线确定计划至治疗时间点与局部失败的关系。

主要发现

  • fSRS的唯一预测因素为肿瘤体积>2.061 cm3。
  • 按分次或生物有效剂量比较,局部失败、毒性或生存无差异。
  • 生存较差的预测因素为年龄、颅外疾病、全脑放疗史和体积。
  • 受试者工作特征分析确定10天为局部失败的潜在因素。
  • 1年局部控制率:间隔前治疗患者为96.48%,间隔后治疗患者为76.92%(P = .0005)。

临床怎么用

  • 分次立体定向放射外科是体积较大、不适合单次SRS患者的安全有效替代方案。
  • 作者认为应尽快治疗这些患者,因为本研究中延迟显示影响局部控制。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Brain metastases are a common development in patients with malignant solid tumors. Stereotactic radiosurgery (SRS) has a long track record of effectively and safely treating these patients, with some limitations to the use of single fraction SRS based on size and volume. In this study, we reviewed outcomes of patients treated using SRS and fractionated SRS (fSRS) to compare predictors and outcomes of those treatments. METHODS AND MATERIALS: Two hundred patients treated with SRS or fSRS for intact brain metastases were included. We tabulated baseline characteristics and performed a logistic regression to identify predictors of fSRS. Cox regression was used to identify predictors of survival. Kaplan-Meier analysis was used to calculate survival, local failure, and distant failure rates. A receiver operating characteristic curve was generated to determine timepoint from planning to treatment associated with local failure. RESULTS: The only predictor of fSRS was tumor volume >2.061 cm3. There was no difference in local failure, toxicity, or survival by fractionation of biologically effective dose. Predictors of worse survival were age, extracranial disease, history of whole brain radiation therapy, and volume. Receiver operating characteristic analysis identified 10 days as potential factor in local failure. At 1 year, local control was 96.48 and 76.92% for those patients treated before or after that interval, respectively (P = .0005). CONCLUSIONS: Fractionated SRS is a safe and effective alternative for patients with larger volume tumors not suitable for single fraction SRS. Care should be taken to treat these patients expeditiously as a delay was shown to affect local control in this study.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Loftus JP, Shepard M, Liang Y, et al. A Comparison of Single Fraction and Multi Fraction Radiosurgery on the Gamma Knife ICON: A Single Institution Review. Adv Radiat Oncol. 2022. PMID: 36845616. doi:10.1016/j.adro.2022.101161

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。